scholarly article | Q13442814 |
P50 | author | Chunqi Qian | Q61139649 |
Xiaoyuan Chen | Q67123714 | ||
Gang Niu | Q67137291 | ||
Dale O Kiesewetter | Q67137408 | ||
Xuyi Yue | Q116997808 | ||
P2093 | author name string | Yu Wang | |
Zhe Wang | |||
Lei Zhu | |||
Ying Ma | |||
P2860 | cites work | Matrix metalloproteinases | Q28140451 |
Matrix metalloproteinases: structures, evolution, and diversification | Q28282370 | ||
Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs). | Q30540289 | ||
Reversible signal regulation system of 19F NMR by redox reactions using a metal complex as a switching module | Q33441064 | ||
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
Matrix metalloproteinases in tumour invasion and metastasis | Q33765792 | ||
Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease | Q33872836 | ||
Systematic study of protein detection mechanism of self-assembling 19F NMR/MRI nanoprobes toward rational design and improved sensitivity | Q33941540 | ||
Activatable molecular systems using homologous near-infrared fluorescent probes for monitoring enzyme activities in vitro, in cellulo, and in vivo | Q34032588 | ||
A symmetrical fluorous dendron-cyanine dye-conjugated bimodal nanoprobe for quantitative 19F MRI and NIR fluorescence bioimaging | Q34052606 | ||
In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrate | Q34054507 | ||
Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. | Q34542211 | ||
Manipulating the power of an additional phase: a flower-like Au-Fe3O4 optical nanosensor for imaging protease expressions in vivo | Q34861321 | ||
In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars. | Q35024494 | ||
MMP-Activated Fluorescence Imaging Detects Early Joint Inflammation in Collagen-Antibody-Induced Arthritis in CC-Chemokine Receptor-2-Null Mice, In-Vivo | Q35094676 | ||
In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity | Q35592730 | ||
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia | Q35780951 | ||
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. | Q35878888 | ||
1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. | Q36336344 | ||
Avoiding steric congestion in dendrimer growth through proportionate branching: a twist on da Vinci's rule of tree branching | Q36802314 | ||
Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging | Q37003678 | ||
Tracking immune cells in vivo using magnetic resonance imaging | Q37455363 | ||
Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy | Q37624281 | ||
Characterization of early neovascular response to acute lung ischemia using simultaneous (19)F/ (1)H MR molecular imaging. | Q37626285 | ||
Quantitative magnetic resonance fluorine imaging: today and tomorrow | Q37766558 | ||
New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression | Q37948607 | ||
Clinical perspectives of hybrid proton-fluorine magnetic resonance imaging and spectroscopy | Q38065015 | ||
Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes | Q39228772 | ||
Radioactive smart probe for potential corrected matrix metalloproteinase imaging | Q39268473 | ||
Development of MRI/NIRF 'activatable' multimodal imaging probe based on iron oxide nanoparticles | Q39498407 | ||
MMP-2: expression, activation and inhibition | Q41105675 | ||
Multi-chromatic pH-activatable 19F-MRI nanoprobes with binary ON/OFF pH transitions and chemical-shift barcodes | Q42606243 | ||
Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat. | Q43134563 | ||
CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging | Q43138300 | ||
Specific detection and imaging of enzyme activity by signal-amplifiable self-assembling (19)F MRI probes | Q43874065 | ||
Dual-function probe to detect protease activity for fluorescence measurement and 19F MRI. | Q46057320 | ||
Paramagnetic relaxation-based 19f MRI probe to detect protease activity | Q46836886 | ||
Relaxometric studies of gadolinium-functionalized perfluorocarbon nanoparticles for MR imaging. | Q50623896 | ||
On-off regulation of 19F magnetic resonance signals based on pH-sensitive PEGylated nanogels for potential tumor-specific smart 19F MRI probes. | Q50923531 | ||
A tumor-environment-responsive nanocarrier that evolves its surface properties upon sensing matrix metalloproteinase-2 and initiates agglomeration to enhance T₂ relaxivity for magnetic resonance imaging | Q57184908 | ||
Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging | Q57185539 | ||
Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes | Q77067755 | ||
Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo | Q79792625 | ||
Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes | Q80349976 | ||
Potent mechanism-based inhibitors for matrix metalloproteinases | Q80940021 | ||
Heat-initiated detection for reduced glutathione with ¹⁹F NMR probes based on modified gold nanoparticles | Q85484542 | ||
P4510 | describes a project that uses | magnetic resonance imaging | Q161238 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 4208-4217 | |
P577 | publication date | 2014-10-13 | |
P1433 | published in | Molecular Pharmaceutics | Q3011140 |
P1476 | title | Novel 19F activatable probe for the detection of matrix metalloprotease-2 activity by MRI/MRS. | |
P478 | volume | 11 |
Q64086888 | Accelerated F·MRI Detection of Matrix Metalloproteinase-2/-9 through Responsive Deactivation of Paramagnetic Relaxation Enhancement |
Q55086950 | Fluorinated EuII-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging. |
Q55301142 | Fluorinated Paramagnetic Complexes: Sensitive and Responsive Probes for Magnetic Resonance Spectroscopy and Imaging. |
Q38895968 | Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging |
Q47269748 | Local Intratracheal Delivery of Perfluorocarbon Nanoparticles to Lung Cancer Demonstrated with Magnetic Resonance Multimodal Imaging |
Q51620937 | Molecular Sensing with Hyperpolarized (129) Xe Using Switchable Chemical Exchange Relaxation Transfer. |
Q36373909 | Multifunctional nanoprobes for both fluorescence and 19F magnetic resonance imaging |
Q91687352 | Neutrophil Elastase Activity Imaging: Recent Approaches in the Design and Applications of Activity-Based Probes and Substrate-Based Probes |
Q46736339 | Preliminary 19F-MRS Study of Tumor Cell Proliferation with 3'-deoxy-3'-fluorothymidine and Its Metabolite (FLT-MP). |
Q38761680 | Small BODIPY Probes for Combined Dual (19) F MRI and Fluorescence Imaging |
Q38798242 | The N-terminus of the yeast G protein-coupled receptor Ste2p plays critical roles in surface expression, signaling, and negative regulation |
Q50110755 | Towards an MMP-2-activated molecular agent for cancer imaging |
Search more.